Literature DB >> 26045521

Presumed latent ocular tuberculosis diagnosed with the positive quantiFERON-TB Gold In-Tube Test in a HLA-A29-positive patient.

Carlos Mario Rangel1, Cesar Atencia2, Jesus Merayo-Lloves3, Alvaro Fernandez-Vega Sanz3.   

Abstract

A 59-year-old Hispanic woman presented with a 3-year history of floaters associated with bilateral reduced visual acuity. Her best-corrected visual acuity (BCVA) was 20/40. Both anterior segments were without inflammation, but fundoscopy showed mild vitreous inflammation and multiple inflammatory choroidal lesions. Tests for inflammatory and infectious diseases were negative except for human leucocyte antigen A29. The patient was diagnosed with birdshot choroidoretinopathy, and treatment was initiated with cyclosporine A 2.5 mg/kg/day. One year after treatment, the patient reported systemic symptoms with no improvement in visual acuity. Fundus findings remained with vitreal inflammation. QuantiFERON-TB Gold In-Tube Test was positive, and a diagnosis of presumed latent ocular tuberculosis (TB) was made. We initiated anti-TB treatment for 9 months. At 6 months of anti-TB therapy, there was no active inflammation. The patient was followed for 2 years with no medications and no active inflammation. Her final BCVA was 20/25. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26045521      PMCID: PMC4460534          DOI: 10.1136/bcr-2015-210206

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis.

Authors:  Young Ae Kang; Hye Won Lee; Seung Sik Hwang; Sang-Won Um; Sung Koo Han; Young-Soo Shim; Jae-Joon Yim
Journal:  Chest       Date:  2007-05-15       Impact factor: 9.410

2.  Birdshot chorioretinopathy: clinical characteristics and evolution.

Authors:  H A Priem; J A Oosterhuis
Journal:  Br J Ophthalmol       Date:  1988-09       Impact factor: 4.638

3.  Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy.

Authors:  Szilard Kiss; Muna Ahmed; Erik Letko; C Stephen Foster
Journal:  Ophthalmology       Date:  2005-06       Impact factor: 12.079

4.  Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: a case-control study.

Authors:  Marcus Ang; Alireza Hedayatfar; Wanling Wong; Soon-Phaik Chee
Journal:  Br J Ophthalmol       Date:  2011-06-30       Impact factor: 4.638

5.  Efficacy of low-dose methotrexate treatment in birdshot chorioretinopathy.

Authors:  Aniki Rothova; Annette Ossewaarde-van Norel; Leonoor I Los; Tos T J M Berendschot
Journal:  Retina       Date:  2011-06       Impact factor: 4.256

Review 6.  Birdshot chorioretinopathy.

Authors:  Kayur H Shah; Ralph D Levinson; Fei Yu; Raquel Goldhardt; Lynn K Gordon; Christine R Gonzales; John R Heckenlively; Peter J Kappel; Gary N Holland
Journal:  Surv Ophthalmol       Date:  2005 Nov-Dec       Impact factor: 6.048

7.  Birdshot retinochoroidopathy: ocular complications and visual impairment.

Authors:  Jennifer E Thorne; Douglas A Jabs; George B Peters; David Hair; James P Dunn; John H Kempen
Journal:  Am J Ophthalmol       Date:  2005-07       Impact factor: 5.258

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.